Literature DB >> 18608693

An exploratory study of long-term neurocognitive outcomes following recovery from opportunistic brain infections in HIV+ adults.

Andrew J Levine1, Charles H Hinkin, Kazuhiro Ando, Gianni Santangelo, Mariana Martinez, Miguel Valdes-Sueiras, Ernestina H Saxton, Glen Mathisen, Deborah L Commins, Ardis Moe, Charles Farthing, Elyse J Singer.   

Abstract

Central nervous system opportunistic infections (CNS-OI) are a significant cause of morbidity and mortality in AIDS. While current interventions are increasingly successful in treating CNS-OI, little information exists regarding long-term behavioral outcomes among survivors. In this exploratory study we examined neurocognitive data among three groups of adults with different AIDS-related CNS-OI: 15 with past cryptococcal meningitis (CM), 8 with toxoplasmosis encephalitis (TE), and 8 with progressive multifocal leukoencephalopathy (PML). A group of 61 individuals with AIDS, but without CNS-OI, was used as a comparison group. A battery of standardized neuropsychological tests assessing a variety of cognitive domains was administered upon entry. Results indicate that individuals with a history of CNS-OI were most impaired on measures of cognitive and psychomotor speed relative to the HIV+ comparison group. Among the CNS-OI groups, individuals with history of TE had the most severe and varied deficits. The results are discussed in relation to what is known about the neuropathological consequences of the various CNS-OIs. While this is the first systematic group study of residual CNS-OI effects on neurocognitive function, future studies employing more participants, perhaps focusing on specific CNS-OIs, will further characterize the long-term outcomes in AIDS-related CNS-OI.

Entities:  

Mesh:

Year:  2008        PMID: 18608693      PMCID: PMC2886735          DOI: 10.1080/13803390701819036

Source DB:  PubMed          Journal:  J Clin Exp Neuropsychol        ISSN: 1380-3395            Impact factor:   2.475


  27 in total

1.  HIV-related neuropathology, 1985 to 1999: rising prevalence of HIV encephalopathy in the era of highly active antiretroviral therapy.

Authors:  Jutta K Neuenburg; Hans R Brodt; Brian G Herndier; Markus Bickel; Peter Bacchetti; Richard W Price; Robert M Grant; Wolfgang Schlote
Journal:  J Acquir Immune Defic Syndr       Date:  2002-10-01       Impact factor: 3.731

2.  Paced auditory serial-addition task: a measure of recovery from concussion.

Authors:  D M Gronwall
Journal:  Percept Mot Skills       Date:  1977-04

3.  Mania with cryptococcal meningitis in two AIDS patients.

Authors:  D J Johannessen; L G Wilson
Journal:  J Clin Psychiatry       Date:  1988-05       Impact factor: 4.384

4.  Interrater reliability of the Psychiatric Research Interview for Substance and Mental Disorders in an HIV-infected cohort: experience of the National NeuroAIDS Tissue Consortium.

Authors:  S Morgello; C E Holzer; E Ryan; C Young; M Naseer; S A Castellon; A B Frol; J Hampton Atkinson; B B Gelman; I Grant; E J Singer
Journal:  Int J Methods Psychiatr Res       Date:  2006       Impact factor: 4.035

5.  Early psychomotor slowing predicts the development of HIV dementia and autopsy-verified HIV encephalitis.

Authors:  O Dunlop; R Bjørklund; J N Bruun; R Evensen; A K Goplen; K Liestøl; M Sannes; J Maehlen; B Myrvang
Journal:  Acta Neurol Scand       Date:  2002-04       Impact factor: 3.209

6.  Assessing HIV-associated dementia: modified HIV dementia scale versus the Grooved Pegboard.

Authors:  Henraya F Davis; Richard L Skolasky; Ola A Selnes; David M Burgess; Justin C McArthur
Journal:  AIDS Read       Date:  2002-01

7.  Incidence of acquired immunodeficiency syndrome-associated opportunistic diseases and the effect of treatment on a cohort of 1115 patients infected with human immunodeficiency virus, 1989-1997.

Authors:  Francisco-Javier San-Andrés; Rafael Rubio; Jesús Castilla; Federico Pulido; Guillermo Palao; Inmaculada de Pedro; José-Ramón Costa; Angel del Palacio
Journal:  Clin Infect Dis       Date:  2003-04-14       Impact factor: 9.079

8.  Performance of Spanish speakers on the Mattis dementia rating scale (MDRS).

Authors:  Scott A Lyness; Isis Hernandez; Helena C Chui; Evelyn L Teng
Journal:  Arch Clin Neuropsychol       Date:  2006-10-31       Impact factor: 2.813

Review 9.  Human immunodeficiency virus dementia: evidence of a subcortical process from studies of fine finger movements.

Authors:  Gabriele Arendt; Hans-Jürgen von Giesen
Journal:  J Neurovirol       Date:  2002-12       Impact factor: 2.643

10.  Safe interruption of maintenance therapy against previous infection with four common HIV-associated opportunistic pathogens during potent antiretroviral therapy.

Authors:  Ole Kirk; Peter Reiss; Caterina Uberti-Foppa; Markus Bickel; Jan Gerstoft; Christian Pradier; Ferdinand W Wit; Bruno Ledergerber; Jens D Lundgren; Hansjakob Furrer
Journal:  Ann Intern Med       Date:  2002-08-20       Impact factor: 25.391

View more
  18 in total

1.  Neuropsychological evaluation and follow up in jcv- and non-jcv-related leukoencephalopathies in HIV infection.

Authors:  C Zucchella; E Sinforiani; E Tavazzi; S Del Bue; S Novati; R Maserati; M Ceroni; S Bastianello; L Minoli; P Ferrante; E Marchioni
Journal:  Neurol Sci       Date:  2011-06-01       Impact factor: 3.307

2.  Predictors of neurocognitive outcomes on antiretroviral therapy after cryptococcal meningitis: a prospective cohort study.

Authors:  Renee Donahue Carlson; Melissa A Rolfes; Kate E Birkenkamp; Noeline Nakasujja; Radha Rajasingham; David B Meya; David R Boulware
Journal:  Metab Brain Dis       Date:  2014-01-09       Impact factor: 3.584

Review 3.  Epidemiology, Pathophysiology, Diagnosis, and Management of Cerebral Toxoplasmosis.

Authors:  Hany M Elsheikha; Christina M Marra; Xing-Quan Zhu
Journal:  Clin Microbiol Rev       Date:  2020-11-25       Impact factor: 26.132

4.  Antioxidant sestrin-2 redistribution to neuronal soma in human immunodeficiency virus-associated neurocognitive disorders.

Authors:  Virawudh Soontornniyomkij; Benchawanna Soontornniyomkij; David J Moore; Ben Gouaux; Eliezer Masliah; Spencer Tung; Harry V Vinters; Igor Grant; Cristian L Achim
Journal:  J Neuroimmune Pharmacol       Date:  2012-03-27       Impact factor: 4.147

5.  Cerebral β-amyloid deposition predicts HIV-associated neurocognitive disorders in APOE ε4 carriers.

Authors:  Virawudh Soontornniyomkij; David J Moore; Ben Gouaux; Benchawanna Soontornniyomkij; Erick T Tatro; Anya Umlauf; Eliezer Masliah; Andrew J Levine; Elyse J Singer; Harry V Vinters; Benjamin B Gelman; Susan Morgello; Mariana Cherner; Igor Grant; Cristian L Achim
Journal:  AIDS       Date:  2012-11-28       Impact factor: 4.177

6.  Increased cortical expression of FK506 binding protein-51 in HIV-associated neurocognitive disorders.

Authors:  Virawudh Soontornniyomkij; Ian P Everall; David J Moore; Ben Gouaux; Erick T Tatro; Vadim Gospodarev; Eliezer Masliah; Nicole S Yin; Harry V Vinters; Cristian L Achim
Journal:  J Neurovirol       Date:  2012-01-11       Impact factor: 2.643

Review 7.  Neurobehavioral Manifestations of Human Immunodeficiency Virus/AIDS: Diagnosis and Treatment.

Authors:  Elyse J Singer; April D Thames
Journal:  Neurol Clin       Date:  2016-02       Impact factor: 3.806

Review 8.  Neurologic presentations of AIDS.

Authors:  Elyse J Singer; Miguel Valdes-Sueiras; Deborah Commins; Andrew Levine
Journal:  Neurol Clin       Date:  2010-02       Impact factor: 3.806

9.  Neurocognitive impairment in HIV-infected individuals with previous syphilis.

Authors:  C M Marra; R Deutsch; A C Collier; S Morgello; S Letendre; D Clifford; B Gelman; J McArthur; J A McCutchan; D M Simpson; N A Duarte; R K Heaton; I Grant
Journal:  Int J STD AIDS       Date:  2013-06-14       Impact factor: 1.359

Review 10.  An algorithmic approach to structural imaging in dementia.

Authors:  Lorna Harper; Frederik Barkhof; Philip Scheltens; Jonathan M Schott; Nick C Fox
Journal:  J Neurol Neurosurg Psychiatry       Date:  2013-10-16       Impact factor: 10.154

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.